AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Microsoft
MSFT
|
+$633M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$435M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$397M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$328M |
| 5 |
Regency Centers
REG
|
+$217M |
Top Sells
| 1 |
AET
Aetna Inc
AET
|
+$467M |
| 2 |
Crown Castle
CCI
|
+$339M |
| 3 |
Starbucks
SBUX
|
+$237M |
| 4 |
Citigroup
C
|
+$196M |
| 5 |
Gartner
IT
|
+$194M |
Sector Composition
| 1 | Technology | 16.23% |
| 2 | Healthcare | 15.27% |
| 3 | Financials | 15.11% |
| 4 | Consumer Discretionary | 11.41% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Civitas Resources
CIVI
$3.13B
| $473K | ﹤0.01% |
22,900
-4,180
| -15% | -$86.3K |
|
|
ORC
2502
Orchid Island Capital
ORC
$1.04B
| $467K | ﹤0.01% |
14,628
+1,187
| +9% | +$37.9K |
|
|
AGEN
2503
Agenus
AGEN
$154M
| $463K | ﹤0.01% |
9,920
+1,340
| +16% | +$62.5K |
|
|
ACBI
2504
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $463K | ﹤0.01% |
28,297
+8,879
| +46% | +$145K |
|
2505
ANI Pharmaceuticals
ANIP
$2.11B
| $461K | ﹤0.01% |
10,250
| – | – |
|
2506
Manitowoc
MTW
$357M
| $460K | ﹤0.01% |
31,130
-21,480
| -41% | -$317K |
|
|
RARX
2507
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $460K | ﹤0.01% |
25,300
+7,900
| +45% | +$144K |
|
|
BCTF
2508
DELISTED
Bancorp 34, Inc. Common Stock
BCTF
| $459K | ﹤0.01% |
31,034
+7,680
| +33% | +$114K |
|
|
AXDX
2509
DELISTED
Accelerate Diagnostics
AXDX
| $458K | ﹤0.01% |
3,985
+14
| +0.4% | +$1.61K |
|
2510
National CineMedia
NCMI
$423M
| $456K | ﹤0.01% |
7,037
-1,809
| -20% | -$117K |
|
2511
Weis Markets
WMK
$1.73B
| $456K | ﹤0.01% |
9,551
| – | – |
|
2512
Myers Industries
MYE
$602M
| $455K | ﹤0.01% |
30,100
-1,700
| -5% | -$25.7K |
|
2513
St. Joe Company
JOE
$2.91B
| $453K | ﹤0.01% |
34,400
-25,600
| -43% | -$337K |
|
2514
Standard BioTools
LAB
$489M
| $453K | ﹤0.01% |
52,500
+4,500
| +9% | +$38.8K |
|
2515
Accuray
ARAY
$175M
| $452K | ﹤0.01% |
132,491
+10,700
| +9% | +$36.5K |
|
2516
Honda
HMC
$44.4B
| $452K | ﹤0.01% |
17,072
-8,097
| -32% | -$214K |
|
2517
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.14B
| $452K | ﹤0.01% |
9,448
-852
| -8% | -$40.8K |
|
2518
Assembly Biosciences
ASMB
$171M
| $450K | ﹤0.01% |
1,658
| – | – |
|
2519
Veeco
VECO
$1.52B
| $450K | ﹤0.01% |
60,792
| – | – |
|
|
TSC
2520
DELISTED
TriState Capital Holdings, Inc.
TSC
| $450K | ﹤0.01% |
23,100
+3,700
| +19% | +$72.1K |
|
|
VRAY
2521
DELISTED
ViewRay, Inc.
VRAY
| $449K | ﹤0.01% |
73,900
| – | – |
|
2522
Rhythm Pharmaceuticals
RYTM
$6.66B
| $446K | ﹤0.01% |
16,600
+3,900
| +31% | +$105K |
|
2523
Impinj
PI
$5.53B
| $444K | ﹤0.01% |
30,500
+3,100
| +11% | +$45.1K |
|
|
ANH
2524
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $444K | ﹤0.01% |
109,803
-4,000
| -4% | -$16.2K |
|
2525
iShares Select Dividend ETF
DVY
$20.7B
| $441K | ﹤0.01% |
4,939
-156
| -3% | -$13.9K |
|